Riccardo Bartoletti

ORCID: 0000-0002-0021-0302
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bladder and Urothelial Cancer Treatments
  • Urinary Bladder and Prostate Research
  • Prostate Cancer Diagnosis and Treatment
  • Urinary Tract Infections Management
  • Urinary and Genital Oncology Studies
  • Urological Disorders and Treatments
  • Prostate Cancer Treatment and Research
  • Genital Health and Disease
  • Urologic and reproductive health conditions
  • Pelvic floor disorders treatments
  • Sexual function and dysfunction studies
  • Pediatric Urology and Nephrology Studies
  • Hormonal and reproductive studies
  • Kidney Stones and Urolithiasis Treatments
  • COVID-19 and healthcare impacts
  • Cervical Cancer and HPV Research
  • Renal cell carcinoma treatment
  • Reproductive tract infections research
  • Ureteral procedures and complications
  • Esophageal Cancer Research and Treatment
  • Colorectal Cancer Screening and Detection
  • Renal and related cancers
  • Bacterial Identification and Susceptibility Testing
  • Infectious Disease Case Reports and Treatments
  • Healthcare cost, quality, practices

University of Pisa
2016-2025

Azienda Ospedaliera Universitaria Pisana
2024

Ospedale Cisanello
2021-2022

Rabin Medical Center
2021

Ospedale Santa Maria Annunziata
2006-2019

University of Florence
2009-2018

Azienda Socio Sanitaria Territoriale della Valtellina e Alto Lario
2018

Presidio Ospedaliero
2018

Men's Health Boston
2018

Faculty of Media
2016

The severe acute respiratory syndrome coronavirus 2 and the disease it causes, 2019 (COVID-19) is generating a rapid tragic health emergency in Italy due to need provide assistance an overwhelming number of infected patients and, at same time, treat all non-deferrable oncological benign conditions. A panel Italian urologists has agreed on possible strategies for reorganization urological routine practice set recommendations that should facilitate process rescheduling both surgical outpatient...

10.23736/s0393-2249.20.03846-1 article EN Minerva Urologica e Nefrologica 2020-06-01

Background. Little is known about the role of asymptomatic bacteriuria (AB) treatment in young women affected by recurrent urinary tract infection (UTI). We aimed to evaluate impact AB on recurrence rate among UTI. Methods. A total 673 consecutive with demonstrated from January 2005 December 2009 were prospectively enrolled. Patients split into 2 groups: not treated (group A, n = 312) and B, 361). Microbiological clinical evaluations performed at 3, 6, 12 months. Quality life was also...

10.1093/cid/cis534 article EN Clinical Infectious Diseases 2012-06-07

To evaluate variant histologies (VHs) for disease-specific survival (DSS) in patients with invasive urothelial bladder cancer (BCa) undergoing radical cystectomy (RC).We analysed a multi-institutional cohort of 1082 treated upfront RC cT1-4aN0M0 BCa at eight centres. Univariable and multivariable Cox' regression analyses were used to assess the effect different VHs on DSS overall three stage-based analyses. The stages defined as 'organ-confined' (≤pT2N0), 'locally advanced' (pT3-4N0)...

10.1111/bju.15984 article EN BJU International 2023-02-07

No AccessJournal of Urology1 Jan 1993Orchiectomy and Nilutamide or Placebo as Treatment Metastatic Prostatic Cancer in a Multinational Double-Blind Randomized Trialis companion ofEditorial Comments R.A. Janknegt, C.C. Abbou, R. Bartoletti, L. Bernstein-Hahn, B. Bracken, J.M. Brisset, F. Calais Da Silva, G. Chisholm, E.D. Crawford, F.M.J. Debruyne, G.D. Dijkman, J. Frick, Goedhals, H. Knönagel, P.M. Venner JanknegtR.A. Janknegt , AbbouC.C. Abbou BartolettiR. Bartoletti Bernstein-HahnL....

10.1016/s0022-5347(17)36003-2 article EN The Journal of Urology 1993-01-01

We evaluated the prevalence and estimated incidence risk factors of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients Italy.From January to June 2006 patients from 28 Italian centers who were between 25 50 years old with symptoms consecutively enrolled this prospective epidemiological case-control study. A total 152 subjects similar age, race area origin investigated for infertile couples but otherwise healthy served as controls. All provided a medical...

10.1016/j.juro.2007.08.046 article EN The Journal of Urology 2007-11-10

Objectives To determine if a re‐transurethral resection (TUR), in the presence or absence of muscle at first TUR patients with T1‐high grade (HG)/Grade 3 (G3) bladder cancer, makes difference recurrence, progression, cancer specific (CSS) and overall survival (OS). Patients methods In large retrospective multicentre cohort 2451 T1‐HG/G3 initially treated bacille Calmette–Guérin, 935 (38%) had re‐TUR. According to specimen primary TUR, were divided four groups: group 1 (no muscle, no re‐TUR),...

10.1111/bju.13354 article EN BJU International 2015-10-15

Abstract Background. Women suffering from recurrent urinary tract infections (rUTIs) are routinely treated for asymptomatic bacteriuria (AB), but the consequences of this procedure on antibiotic resistance not fully known. The aim study was to evaluate impact AB treatment among women with rUTIs. Methods. population consisted 2 groups who had previously been enrolled in a randomized clinical trial: group A treated, and B treated. All were scheduled follow-up visits every 6 months, or more...

10.1093/cid/civ696 article EN Clinical Infectious Diseases 2015-08-12

The public health emergency caused by the Coronavirus Disease 2019 (COVID-19) pandemic has resulted in a significant reallocation of resources with consequent reorganization clinical activities also several urological centers. A panel Italian urologists agreed on set recommendations pathways pre-, intra- and post-operative care for patients undergoing urgent procedures or non-deferrable oncological interventions during COVID-19 pandemic. Simplification diagnostic staging pathway to be...

10.23736/s0393-2249.20.03861-8 article EN Minerva Urologica e Nefrologica 2020-06-01

The Global Prevalence of Infections in Urology (GPIU) study is a worldwide-performed point prevalence intended to create surveillance data on antibiotic resistance, type urogenital infections, risk factors and consumption, specifically patients at urological departments with healthcare-associated infections (HAUTI). Investigators registered through web-based application (http://gpiu.esiu.org/). Data collection includes the practice characteristics hospital urology ward. On certain day...

10.3390/pathogens5010010 article EN cc-by Pathogens 2016-01-19

Primary objective was to identify the (1) relationship of clinical severity urosepsis with pathogen spectrum and resistance (2) appropriateness using rates health-care-associated urinary tract infections (HAUTI) as representative urosepsis. The secondary provide an overview pathogens their profile in patients A point prevalence study carried out 70 countries (2003–2013). Population studied included; 408 individuals microbiologically proven urosepsis, 1606 microbiological proof HAUTI 27,542...

10.1007/s00345-015-1722-1 article EN cc-by World Journal of Urology 2015-12-11
Coming Soon ...